DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Claims 22-25 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 9/30/2026.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 1 recites the limitation "that comprises interlaced octagonal cells creating alternate sequence of diamond shaped cells or rhombus bodies at each junction" in lines 33-34. There is insufficient antecedent basis for the term “junction” in the claim, so it is unclear whether the term “junction” is referring to the location of a link, etc.
Additionally appears that the phrase “creating alternate sequence” is missing a term and should be changed to “that creates an alternating sequence”.
Claims 2-20 depends from claim 1 and are indefinite for the same reasons.
Claim 21 recites the limitation "that comprises interlaced octagonal cells creating alternate sequence of diamond shaped cells or rhombus bodies at each junction" in lines 23-24. There is insufficient antecedent basis for the term “junction” in the claim, so it is unclear whether the term “junction” is referring to the location of a link, etc. Additionally appears that the phrase “creating alternate sequence” is missing a term and should be changed to “that creates an alternating sequence”.
Allowable Subject Matter
Claims 1-21 are free of prior art rejections and would be allowable if amended to overcome the 112 rejections.
As allowable subject matter has been indicated, applicant's reply must either comply with all formal requirements or specifically traverse each requirement not complied with. See 37 CFR 1.111(b) and MPEP § 707.07(a).
The following is a statement of reasons for the indication of allowable subject matter:
Prior art discloses various stent designs having hexagonal and/or octagonal cells, and links between undulating rows having openings.
USPAP 2020/0352709 (Gurovich et al.) discloses a stent with rows of hexagonal cells and some links having an opening (62) (Fig. 11).
USPAP 2018/0325660 discloses a stent having hexagonal cells and links (1314) having openings (1336) (Fig. 21).
USPAP 2012/0029619 discloses a stent wherein the struts define a plurality of openings, wherein the openings are for drug delivery.
USPAP 2012/0016458 discloses the concept of a stent frame defining a diamond shaped opening (see 229 in Figure 6a) but the opening is at a peak/valley of an undulating row and not defined by a link.
USPAP 2009/0132027 discloses a stent design having rows of hexagonal cells alternating with a row of diamond shaped cells in sequence with hexagonal cells (Fig. 4).
Prior art fails to disclose or render obvious the particular arrangement of interlaced octagonal cells with an alternating sequence of links defining a rhombus body or diamond shaped opening, in combination with other claimed elements.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SARAH WEBB ALEMAN whose telephone number is (571)272-5749. The examiner can normally be reached M, Tu, Th, Fr 9am - 3pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie Tyson can be reached at 571-272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SARAH W ALEMAN/Primary Examiner, Art Unit 3774